Boc-1,4-cis-ACHA-OH

Boc-1,4-cis-ACHA-OH is a Boc-protected, non-proteinogenic amino acid derivative featuring a constrained cyclohexyl-like side-chain architecture that enforces a cis relationship at the 1,4-disubstituted positions. This stereodefined scaffold is commonly handled as a protected building block for peptide and peptidomimetic assembly, where controlled three-dimensional presentation is used to probe structure-activity relationships and conformational effects. The Boc-protection pattern makes it particularly relevant for downstream coupling workflows that require an N-protected amino acid intermediate rather than a free amino acid salt.

1. Peptidomimetic Building Block

Boc-1,4-cis-ACHA-OH is used by medicinal chemistry groups to construct conformationally restricted peptidomimetics and backbone-modified analogs, where the cis-1,4 stereochemical constraint helps bias local geometry. Researchers incorporate this scaffold into short peptide-like sequences to study how side-chain topology influences binding-site shape complementarity, conformational preferences, and structure-activity trends during lead optimization. The Boc-protected amino functionality supports standard amino acid coupling strategies in synthetic peptide workflows, enabling reliable segment assembly for analog libraries.

2. Protected Amino Acid Coupling

Boc-1,4-cis-ACHA-OH serves as a protected amino acid intermediate for custom peptide synthesis workflows that require an N-protected residue with defined stereochemistry. Peptide synthesis teams use this reagent when they need a specific, rigid side-chain presentation at a chosen position within a sequence, such as in SAR-driven synthesis of constrained analogs, stapled or cyclized peptide fragments, and other stereochemically sensitive constructs. By providing a stable, isolable Boc-protected form, it fits routine procurement and handling practices for building-block-based assembly and downstream purification of peptide intermediates.

3. Conformational SAR Analog Synthesis

Boc-1,4-cis-ACHA-OH is frequently selected for generating conformational SAR panels where the objective is to compare analogs that differ primarily in stereochemical arrangement and side-chain constraint rather than in global composition. Chemical biology and medicinal chemistry laboratories use this type of stereodefined residue to produce analog series that can be evaluated in biochemical assays or binding studies, with the cis-1,4 architecture acting as a structural "handle" for interpreting how restricted conformations affect performance. The protected amino acid format streamlines integration into multi-step synthesis campaigns aimed at producing multiple closely related analogs for rapid iteration.

4. Pharmaceutical Intermediate Development

Boc-1,4-cis-ACHA-OH is also used in the development supply chain for pharmaceutical intermediate synthesis, particularly when a constrained, stereodefined amino acid derivative is required as an input to later-stage assembly. Process and development chemists rely on such Boc-protected building blocks to standardize procurement of stereochemically consistent material for route scouting, scale-up feasibility studies, and the preparation of advanced intermediates used in analog manufacturing. This application leverages the reagent's protected, residue-like form to reduce variability between lots and support reproducible downstream coupling into larger synthetic targets.

1. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists